Annovis Bio Inc is a clinical stage pharmaceutical company focused on developing and commercializing drugs for the treatment of Parkinson's and Alzheimer's diseases and other neuro degenerative diseases. The pipeline products of the company include ANVS-401, ANVS-405 and ANVS-301.
Earnings
see more| Q4 2020 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED)2021-02-20 | ||||||
| REV | |||||||
| Q3 2020 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.150 | ||||||
| REV | 0 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| ANVS | Annovis Bio, Inc. Common Stock | 0.2% | 69.1M |
Annovis Bio, Inc. Common Stock Company Questions & Answers
Q
How do I buy Annovis Bio, Inc. Common Stock (ANVS) stock?
A
You can purchase shares of Annovis Bio, Inc. Common Stock (AMEX: ANVS) through any online brokerage.
Q
Who are Annovis Bio, Inc. Common Stock's (ANVS) main competitors?
A
There are no as such competitors for Annovis Bio, Inc. Common Stock.
Q
What is the target price for Annovis Bio, Inc. Common Stock?
A
There is no analysis for Annovis Bio, Inc. Common Stock
Q
How much is Annovis Bio, Inc. Common Stock (ANVS) stock ?
A
The stock price for Annovis Bio, Inc. Common Stock (AMEX: ANVS) is $10.02 last updated Fri Jan 15 2021 20:45:55 GMT+0000 (Coordinated Universal Time).
Q
When is the next Annovis Bio, Inc. Common Stock (ANVS) dividend?
A
There are no upcoming dividends for Annovis Bio, Inc. Common Stock.
Q
When is Annovis Bio, Inc. Common Stock (AMEX:ANVS) reporting earnings?
A
Annovis Bio, Inc. Common Stock’s Q4 earnings are confirmed from now on February 20, 2021.
Q
When is the upcoming split for ANVS?
A
There is no upcoming split for Annovis Bio, Inc. Common Stock.